In diverse cancer types, considerable coexpression of TPX2 with immune checkpoint genes, including CTLA4, LAG3, TIGIT, PDCD1, CD27, CD28, CD40, CD44, CD48, CD70, CD80, CD86, CD160, CD200, CD244, CD274, and CD276, was found. This evidence concerns the gene CD28 and cancer.